Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study-Reference-Cited by-同舟云学术

Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study

Published:2012-07-10 Issue:9 Volume:27 Page:3560-3567
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Stallone G.,Infante B.,Grandaliano G.,Bristogiannis C.,Macarini L.,Mezzopane D.,Bruno F.,Montemurno E.,Schirinzi A.,Sabbatini M.,Pisani A.,Tataranni T.,Schena F. P.,Gesualdo L.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/9/3560/7639881/gfs264.pdf

Reference36 articles.

1. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16

2. PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

3. Comparison of phenotypes of polycystic kidney disease types 1 and 2

4. Polycystin-1, the Gene Product of PKD1 , Induces Resistance to Apoptosis and Spontaneous Tubulogenesis in MDCK Cells

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management;Seminars in Nephrology;2023-11

2. A Systematic Review of Reported Outcomes in ADPKD Studies;Kidney International Reports;2022-09

3. Rapamycin Inhibitors for Eye Squamous Cell Carcinoma after Renal Transplantation: A Case Report;Kidney and Blood Pressure Research;2021-01-28

4. Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins;Human Molecular Genetics;2020-05-11

5. Use of mammalian target of rapamycin inhibitors in patient with autosomal dominant polycystic kidney disease: an updated meta-analysis;International Urology and Nephrology;2019-10-01